Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:alsoKnownAs |
gptkb:Bisantrene
|
| gptkbp:ATCCode |
L01DB07
|
| gptkbp:CASNumber |
6618-51-5
|
| gptkbp:chemicalFormula |
C22H26N4O2
|
| gptkbp:developedBy |
gptkb:cancer
|
| gptkbp:drugClass |
anthracene derivative
|
| gptkbp:hasInChIKey |
QJYJQKZDHXJXQJ-UHFFFAOYSA-N
|
| gptkbp:hasSMILES |
CC1=CC2=C(C=C1)N(C3=CC=CC=C3N2C4=CC=CC=C4)CCN(CC)CC
|
| gptkbp:hasUNII |
1Q8Q9M8D2E
|
| https://www.w3.org/2000/01/rdf-schema#label |
SD7932
|
| gptkbp:molecularWeight |
378.47 g/mol
|
| gptkbp:PubChem_CID |
2367
CHEMBL2104807 |
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:therapeuticArea |
oncology
|
| gptkbp:usedAs |
antineoplastic agent
|
| gptkbp:bfsParent |
gptkb:Hapton,_Lancashire,_England
|
| gptkbp:bfsLayer |
7
|